| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.TIPS.2006.05.004 |
| P698 | PubMed publication ID | 16762426 |
| P50 | author | Esther Berrocoso | Q55153713 |
| P2093 | author name string | Alain Eschalier | |
| Denis Ardid | |||
| Juan A Micó | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 348-354 | |
| P577 | publication date | 2006-06-09 | |
| P1433 | published in | Trends in Pharmacological Sciences | Q2451474 |
| P1476 | title | Antidepressants and pain | |
| P478 | volume | 27 |
| Q52641632 | A Brief Review of the Pharmacology of Amitriptyline and Clinical Outcomes in Treating Fibromyalgia. |
| Q64934471 | A Dual Noradrenergic Mechanism for the Relief of Neuropathic Allodynia by the Antidepressant Drugs Duloxetine and Amitriptyline. |
| Q37346995 | A combined effect of dextromethorphan and melatonin on neuropathic pain behavior in rats |
| Q49390794 | A comparison of early and late treatments on allodynia and its chronification in experimental neuropathic pain. |
| Q41661599 | A nationwide study of chronic pain prevalence in the general spanish population: identifying clinical subgroups through cluster analysis |
| Q37767601 | A qualitative systematic review of head-to-head randomized controlled trials of oral analgesics in neuropathic pain |
| Q28397499 | Alexithymia is associated with greater risk of chronic pain and negative affect and with lower life satisfaction in a general population: the Hisayama Study |
| Q44784957 | Alleviating pain hypersensitivity through activation of type 4 metabotropic glutamate receptor. |
| Q43055402 | Amitriptyline and tianeptine poisoning treated by naloxone |
| Q38591298 | Amitriptyline for the treatment of fibromyalgia: a comprehensive review |
| Q54976781 | Ammoxetine attenuates diabetic neuropathic pain through inhibiting microglial activation and neuroinflammation in the spinal cord. |
| Q38308671 | An altered spinal serotonergic system contributes to increased thermal nociception in an animal model of depression. |
| Q38815838 | An overview of treatment approaches for chronic pain management |
| Q34590272 | An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy |
| Q47099589 | Analgesic Mechanisms of Antidepressants for Neuropathic Pain |
| Q38687437 | Antidepressant Drugs for Postsurgical Pain: Current Status and Future Directions |
| Q36982694 | Antidepressant agents for the treatment of chronic pain and depression |
| Q33844389 | Antidepressant-Like Effect of the Endogenous Neuroprotective Amine, 1MeTIQ in Clonidine-Induced Depression: Behavioral and Neurochemical Studies in Rats |
| Q42282213 | Antidepressant-like action of the hydromethanolic flower extract of Tagetes erecta L. in mice and its possible mechanism of action |
| Q35029526 | Antidepressant-like activity of turmerone in behavioral despair tests in mice |
| Q24242070 | Antidepressants for non-specific low back pain |
| Q34907407 | Antidepressants for the treatment of chronic pain. |
| Q48349727 | Antidepressants inhibit Nav1.3, Nav1.7, and Nav1.8 neuronal voltage-gated sodium channels more potently than Nav1.2 and Nav1.6 channels expressed in Xenopus oocytes. |
| Q42741360 | Antinociceptive Effects of the Serotonin and Noradrenaline Reuptake Inhibitors Milnacipran and Duloxetine on Vincristine-Induced Neuropathic Pain Model in Mice |
| Q36151369 | Antinociceptive potentiation of pethidine (demerol) by clomipramine in the late phase of formalin test in mice |
| Q36876442 | Anxiolytics may promote locomotor function recovery in spinal cord injury patients |
| Q36593892 | Association Between Placebo-Activated Neural Systems and Antidepressant Responses: Neurochemistry of Placebo Effects in Major Depression |
| Q33569509 | Beta2-adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment |
| Q64941429 | Brain Circuits Mediating Opposing Effects on Emotion and Pain. |
| Q48590698 | Brain energy metabolism is increased by chronic administration of bupropion |
| Q48392103 | Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: involvement of supraspinal serotonergic system and GABAA receptor |
| Q40197087 | Chronic pain causes a persistent anxiety state leading to increased ethanol intake in CD1 mice. |
| Q46709181 | Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice |
| Q38777501 | Cortical and subcortical modulation of pain |
| Q38057418 | Current pharmacological treatments for tinnitus |
| Q90625255 | Delta opioid receptors are essential to the antiallodynic action of Β2-mimetics in a model of neuropathic pain |
| Q42944617 | Depression-like behavior and mechanical allodynia are reduced by bis selenide treatment in mice with chronic constriction injury: a comparison with fluoxetine, amitriptyline, and bupropion |
| Q41942529 | Design, synthesis, and biological evaluation of a series of bifunctional ligands of opioids/SSRIs |
| Q90623147 | Determination of tricyclic antidepressants in human urine samples by the three-step sample pretreatment followed by HPLC-UV analysis: an efficient analytical method for further pharmacokinetic and forensic studies |
| Q91969140 | Discovery of aryl sulfonamide-selective Nav1.7 inhibitors with a highly hydrophobic ethanoanthracene core |
| Q28572151 | Disrupting 5-HT(2A) receptor/PDZ protein interactions reduces hyperalgesia and enhances SSRI efficacy in neuropathic pain |
| Q35947915 | Drug management of visceral pain: concepts from basic research |
| Q28552863 | Duloxetine Inhibits Microglial P2X4 Receptor Function and Alleviates Neuropathic Pain after Peripheral Nerve Injury |
| Q52650242 | Early Life Stress, Depression And Parkinson's Disease: A New Approach. |
| Q36776500 | Effect of Motor Impairment on Analgesic Efficacy of Dopamine D2/3 Receptors in a Rat Model of Neuropathy |
| Q42048746 | Effect of glibenclamide on antinociceptive effects of antidepressants of different classes |
| Q44521978 | Effectiveness of low-dose milnacipran for a patient suffering from pain disorder with delusional disorder (somatic type) in the orofacial region |
| Q37095221 | Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats |
| Q35567536 | Engagement of descending inhibition from the rostral ventromedial medulla protects against chronic neuropathic pain |
| Q38913057 | Evaluation and Management of SCI-Associated Pain |
| Q37254569 | Evaluation of the analgesic effects of ammoxetine, a novel potent serotonin and norepinephrine reuptake inhibitor |
| Q35036180 | Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain? |
| Q24612607 | Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity |
| Q36662841 | Exacerbated mechanical allodynia in rats with depression-like behavior |
| Q34669501 | Factors associated with chronic pain in patients with bipolar depression: a cross-sectional study |
| Q45400778 | Ferulic acid increases pain threshold and ameliorates depression-like behaviors in reserpine-treated mice: behavioral and neurobiological analyses |
| Q35169472 | Fisetin exerts antihyperalgesic effect in a mouse model of neuropathic pain: engagement of spinal serotonergic system |
| Q38205030 | Fluoxetine: a case history of its discovery and preclinical development. |
| Q38317178 | Improving acute pain management in emergency medicine |
| Q42143662 | Inhibitory action of antidepressants on mouse Betaine/GABA transporter (BGT1) heterologously expressed in cell cultures |
| Q82343574 | Irritable bowel syndrome, levator ani syndrome, proctalgia fugax and chronic pelvic and perineal pain |
| Q37359337 | Is low-dose amitriptyline effective in the management of chronic low back pain? Study protocol for a randomised controlled trial |
| Q38634594 | Local antinociceptive action of fluoxetine in the rat formalin assay: Role of L-arginine-nitric oxide-cGMP-KATP channel pathway. |
| Q34012766 | Low-dose amitriptyline for treatment of persistent arm pain due to repetitive use |
| Q50072130 | Management of chronic neuropathic pain with single and compounded topical analgesics |
| Q79770423 | Management of painful neuropathies |
| Q37130760 | Mechanical and cold hypersensitivity in nerve-injured C57BL/6J mice is not associated with fear-avoidance- and depression-related behaviour |
| Q46289408 | Medical and Psychiatric Effects of Long-Term Dependence on High Dose of tramadol |
| Q30978672 | Medically unexplained pain complaints are associated with underlying unrecognized mood disorders in primary care |
| Q37791048 | Methylxanthines and Pain |
| Q80405802 | Mice lacking central serotonergic neurons show enhanced inflammatory pain and an impaired analgesic response to antidepressant drugs |
| Q38090730 | Milnacipran for fibromyalgia: a useful addition to the treatment armamentarium |
| Q92669907 | Monoamines as Drug Targets in Chronic Pain: Focusing on Neuropathic Pain |
| Q35748006 | Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia |
| Q34664000 | Myofascial pain syndrome: a treatment review |
| Q38189561 | Neuronal and immunological basis of action of antidepressants in chronic pain - clinical and experimental studies |
| Q38113229 | Neuropathic pain and pharmacological treatment. |
| Q35245083 | Neuropathic pain: a personal case reflection on a critical incident |
| Q33721812 | New treatments for chronic prostatitis/chronic pelvic pain syndrome |
| Q39015447 | Novel 1-(2-pyrimidin-2-yl)piperazine derivatives as selective monoamine oxidase (MAO)-A inhibitors |
| Q37692191 | Novel strategies for the treatment of inflammatory hyperalgesia |
| Q44350929 | Opioid Receptors Contribute to Antinociceptive Effect of Tianeptine on Colorectal Distension-Induced Visceral Pain in Rats |
| Q33802651 | Pain and Psychology-A Reciprocal Relationship |
| Q44862179 | Pain as a symptom of depression: Prevalence and clinical correlates in patients attending psychiatric clinics |
| Q35479887 | Paroxetine alleviates rat limb post-ischemia induced allodynia through GRK2 upregulation in superior cervical ganglia |
| Q38120495 | Pharmacological management of depression in patients with cancer: practical considerations |
| Q43210411 | Pharmacological treatment of fibromyalgia syndrome: new developments |
| Q48681759 | Plasma levels of milnacipran and its effectiveness for the treatment of chronic pain in the orofacial region |
| Q43202783 | Preclinical characterization of BRL 44408: antidepressant- and analgesic-like activity through selective alpha2A-adrenoceptor antagonism |
| Q94459409 | Psychotropic and Opioid-Based Medication Use among Economically Disadvantaged African-American Older Adults |
| Q48414706 | Quantitative mass spectrometry analysis reveals that deletion of the TRPV1 receptor in mice alters substance P and neurokinin A expression in the central nervous system |
| Q33624442 | Resilience and Vulnerability to Pain and Inflammation in the Hippocampus |
| Q28295546 | Role of serotonin 5-HT1A and opioid receptors in the antiallodynic effect of tramadol in the chronic constriction injury model of neuropathic pain in rats |
| Q46650015 | Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice |
| Q44336883 | Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antinociceptive response in the presence of competitive antagonism: the interaction between tramadol and its active metabolite on micro-opioid agonism and monoamine reuptake inhibitio |
| Q60916595 | Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55 |
| Q42669411 | Spotlight on pain: optogenetic approaches for interrogating somatosensory circuits |
| Q64257256 | Strategies to Treat Chronic Pain and Strengthen Impaired Descending Noradrenergic Inhibitory System |
| Q59791928 | Sulforaphane Inhibited the Nociceptive Responses, Anxiety- and Depressive-Like Behaviors Associated With Neuropathic Pain and Improved the Anti-allodynic Effects of Morphine in Mice |
| Q39248730 | The analgesic effect of different antidepressants combined with aspirin on thermally induced pain in Albino mice |
| Q35974778 | The antiallodynic action of pregabalin in neuropathic pain is independent from the opioid system |
| Q28269018 | The atypical antidepressant mianserin exhibits agonist activity at κ-opioid receptors |
| Q52148966 | The effect of serotonin-noradrenaline reuptake inhibitor duloxetine on the intervertebral disk-related radiculopathy in rats. |
| Q48593808 | The effects of prenatal maternal depressive symptoms on pain scores in the early postpartum period |
| Q39202075 | The failure of the antidepressant drug discovery process is systemic. |
| Q26776329 | The imidazoline receptors and ligands in pain modulation |
| Q38191866 | The mu-opioid receptor agonist/noradrenaline reuptake inhibition (MOR-NRI) concept in analgesia: the case of tapentadol |
| Q27011310 | The perception and endogenous modulation of pain |
| Q97418640 | The polysemy of psychotropic drugs: continuity and overlap between neuroenhancement, treatment, prevention, pain relief, and pleasure-seeking in a clinical setting |
| Q26770043 | Tinnitus and its current treatment--Still an enigma in medicine |
| Q47598680 | Topical amitriptyline and ketamine for post-herpetic neuralgia and other forms of neuropathic pain |
| Q34376548 | Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development |
| Q53814033 | Transformation of Lactuca sativa L. with rol C gene results in increased antioxidant potential and enhanced analgesic, anti-inflammatory and antidepressant activities in vivo. |
| Q34912798 | Transient receptor potential channels: targeting pain at the source |
| Q38213185 | Treatment of abdominal pain in irritable bowel syndrome. |
| Q36904884 | Treatment of fibromyalgia and its symptoms |
| Q37106939 | Treatment options and patient perspectives in the management of fibromyalgia: future trends |
| Q48173127 | Undiagnosed mood disorders and sleep disturbances in primary care patients with chronic musculoskeletal pain |
| Q34706201 | Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites |
| Q83274877 | [Tapentadol: with two mechanisms of action in one molecule effective against nociceptive and neuropathic pain. Preclinical overview] |
| Q55284298 | α2- and β2-Adrenoreceptor-Mediated Efficacy of the Atypical Antidepressant Agomelatine Combined With Gabapentin to Suppress Allodynia in Neuropathic Rats With Ligated Infraorbital or Sciatic Nerve. |
| Q35039212 | κ-Opioid receptors are not necessary for the antidepressant treatment of neuropathic pain |
Search more.